銳迪國際科技有限公司 Company Information
Company Name:
RD International Technology Co., Limited
Tel:
-
Email:
market@ubiochem.com
Nationality:
China
WebSite:
www.ruidiresearch.com
Product List:
9180
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
Product List
RTC-5
1423077-49-9
CCT365623 hydrochloride
2126136-98-7
SC99
882290-02-0
JAK/HDAC-IN-1
2284621-75-4
EGFR-IN-8
2407957-87-1
AS2863619 free base
2241300-50-3
AS2863619
2241300-51-4
M-110
1395048-49-3
STAT3-IN-3
2361304-26-7
SI-109
2429877-30-3
Mavelertinib
1776112-90-3
EGFR-IN-11
2463200-44-2
Cenisertib
871357-89-0
EMI56
2414374-41-5
BD750
892686-59-8
SGI-1776
1025065-69-3
Tesevatinib
781613-23-8
Afatinib impurity 11
1402086-20-7
AG-1478
153436-53-4
Oclacitinib maleate
1640292-55-2
(Rac)-JBJ-04-125-02
2140807-05-0
Mobocertinib
1847461-43-1
Mobocertinib succinate
2389149-74-8
Protosappanin A
102036-28-2
G5-7
939681-36-4
PKI-166
187724-61-4
Tyrphostin AG30
122520-79-0
JND3229
2260886-64-2
Erlotinib D6 hydrochloride
1189953-78-3
BMS-599626 Hydrochloride
873837-23-1
UC-514321
299420-83-0
Gefitinib-based PROTAC 3
2230821-27-7
PF-06700841 P-Tosylate
2140301-96-6
SHR0302
1445987-21-2
Almonertinib
1899921-05-1
Almonertinib hydrochloride
2134096-03-8
CK2/ERK8-IN-1
1085822-09-8
Chrysophanol
481-74-3
JCN037
2305154-31-6
JAK2-IN-6
353512-04-6
Napabucasin
83280-65-3
GLPG0634 analog
1206101-20-3
Mutant EGFR inhibitor
1421373-62-7
CP-724714
383432-38-0
NVP-BSK805 dihydrochloride
1942919-79-0
Homoharringtonine
26833-87-4
NSC 74859
501919-59-1
Icotinib Hydrochloride
1204313-51-8
Baricitinib phosphate
1187595-84-1
RGB-286638
784210-87-3
AZD1208
1204144-28-4
Tyrphostin 23
118409-57-7
Rociletinib hydrobromide
1446700-26-0
Osimertinib mesylate
1421373-66-1
AG-825
149092-50-2
Cerdulatinib hydrochloride
1369761-01-2
SH-4-54
1456632-40-8
GDC-0339
1428569-85-0
Itacitinib adipate
1334302-63-4
Tarloxotinib bromide
1636180-98-7
Ochromycinone
111540-00-2
TCS PIM-1 1
491871-58-0
CX-6258
1202916-90-2
CX-6258 hydrochloride hydrate
1353858-99-7
CX-6258 hydrochloride
1353859-00-3
Zorifertinib
1626387-80-1
Lifirafenib
1446090-79-4
CHZ868
1895895-38-1
Lavendustin A
125697-92-9
PIM-447 dihydrochloride
1820565-69-2
JAK3-IN-1
1805787-93-2
Ilginatinib maleate
1354799-87-3
Ilginatinib
1239358-86-1
Ilginatinib hydrochloride
1239358-85-0
Naquotinib mesylate
1448237-05-5
EGFR-IN-3
1660963-42-7
Avitinib maleate
1557268-88-8
NRC-2694
936446-61-6
PF-06459988
1428774-45-1
Neratinib
698387-09-6
Tarlox-TKI
2135696-72-7
Ruxolitinib (S enantiomer)
941685-37-6
Lestaurtinib
111358-88-4
Gefitinib hydrochloride
184475-55-6
Gefitinib D8
857091-32-8
Lapatinib ditosylate
388082-77-7
Mutated EGFR-IN-1
1421372-66-8
Osimertinib dimesylate
2070014-82-1
Niclosamide olamine
1420-04-8
Khellin
82-02-0
Alantolactone
546-43-0
Cryptotanshinone
35825-57-1
Diosgenin
512-04-9
Artesunate
88495-63-0
Cyasterone
17086-76-9
Nitidine chloride
13063-04-2
Curculigoside
85643-19-2
Scutellarin
27740-01-8
Corylifol A
775351-88-7
Tephrosin
76-80-2
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
Copyright 2007© ChemicalBook. All rights reserved.